In 2023, Switzerland led European countries in R&D spending on pharmaceuticals with a significant investment, followed by Belgium and Sweden. While Belgium demonstrated a strong year-on-year growth of 10.2%, countries like Slovakia and Serbia experienced declines, indicating geographic disparities in R&D investment. Companies in Finland and Poland also showed positive variation, suggesting increased focus on innovation.
Future trends to watch include the potential increase in R&D expenditures due to rising demand for innovative pharmaceutical solutions and technological advancements. Additionally, the ongoing economic and regulatory changes in Europe might influence R&D allocation and drive shifts in the pharmaceutical industry's geography.
Top countries in Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing Share by Country (Million Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Switzerland | 44.62 | 2023 | +3.06% | +4.12% | View data |
| 2 | 2 Belgium | 31.28 | 2023 | +7.5% | +10.2% | View data |
| 3 | 3 Sweden | 7.83 | 2023 | +2.07% | +3.35% | View data |
| 4 | 4 Italy | 5 | 2023 | +0.13% | +0.19% | View data |
| 5 | 5 Spain | 3.41 | 2021 | View data | ||
| 6 | 6 Hungary | 3.26 | 2021 | View data | ||
| 7 | 7 Finland | 1.8 | 2023 | +3.53% | +5.6% | View data |
| 8 | 8 Poland | 0.94 | 2023 | +13.37% | +1.91% | View data |
| 9 | 9 Portugal | 0.79 | 2023 | +2.46% | +0.29% | View data |
| 10 | 10 Czech Republic | 0.54 | 2023 | +3.57% | +1.7% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
